[CLDX] QoQ Quarter Result on 31-Dec-2011 [#Q4]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
08-Mar-2012
Financial Year
2011
Quarter
31-Dec-2011 [#Q4]
Profit Trend
QoQ- -8.15%
YoY- -156.18%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Revenue 3,113 2,009 2,433 2,434 2,363 1,952 2,516 15.20%
PBT -15,027 -13,362 -13,083 -12,294 -11,334 -9,802 -9,574 34.94%
Tax -105 -252 -410 268 -288 -158 -268 -46.36%
NP -15,027 -13,773 -13,516 -12,732 -11,772 -10,236 -10,059 30.58%
Tax Rate - - - - - - - -
Total Cost 18,140 15,782 15,949 15,166 14,135 12,188 12,575 27.58%
Ratio Analysis
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
NP Margin -482.72 -685.56 -555.53 -523.09 -498.18 -524.39 -399.80 13.34%
Per Share
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
EPS -3.79 -3.52 -4.04 -3.81 -4.00 -4.10 -4.71 -13.45%
EPS Diluted -3.79 -3.52 -4.04 -3.81 -4.00 -4.10 -4.71 -13.45%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.